TWI341197B - Use of edg receptor binding agents in cancer - Google Patents
Use of edg receptor binding agents in cancerInfo
- Publication number
- TWI341197B TWI341197B TW097139649A TW97139649A TWI341197B TW I341197 B TWI341197 B TW I341197B TW 097139649 A TW097139649 A TW 097139649A TW 97139649 A TW97139649 A TW 97139649A TW I341197 B TWI341197 B TW I341197B
- Authority
- TW
- Taiwan
- Prior art keywords
- cancer
- receptor binding
- binding agents
- edg receptor
- edg
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0211261A GB0211261D0 (en) | 2002-05-16 | 2002-05-16 | Organic compounds |
US39041102P | 2002-06-20 | 2002-06-20 | |
GB0217150A GB0217150D0 (en) | 2002-07-24 | 2002-07-24 | Organic compounds |
US44973903P | 2003-02-24 | 2003-02-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
TW200906381A TW200906381A (en) | 2009-02-16 |
TWI341197B true TWI341197B (en) | 2011-05-01 |
Family
ID=43508462
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW097139649A TWI341197B (en) | 2002-05-16 | 2003-05-15 | Use of edg receptor binding agents in cancer |
TW092113223A TWI340036B (en) | 2002-05-16 | 2003-05-15 | Use of edg receptor binding agents in cancer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW092113223A TWI340036B (en) | 2002-05-16 | 2003-05-15 | Use of edg receptor binding agents in cancer |
Country Status (7)
Country | Link |
---|---|
KR (5) | KR101299873B1 (en) |
DK (1) | DK1944026T3 (en) |
ES (1) | ES2428697T3 (en) |
PL (1) | PL396723A1 (en) |
PT (1) | PT1944026E (en) |
SI (1) | SI1944026T1 (en) |
TW (2) | TWI341197B (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1180026A (en) * | 1997-09-02 | 1999-03-23 | Yoshitomi Pharmaceut Ind Ltd | New immunosuppressant, its use and its identification |
-
2003
- 2003-05-15 ES ES08152489T patent/ES2428697T3/en not_active Expired - Lifetime
- 2003-05-15 KR KR1020117018300A patent/KR101299873B1/en not_active IP Right Cessation
- 2003-05-15 SI SI200332293T patent/SI1944026T1/en unknown
- 2003-05-15 PL PL396723A patent/PL396723A1/en not_active Application Discontinuation
- 2003-05-15 KR KR1020137019570A patent/KR20130088904A/en not_active Application Discontinuation
- 2003-05-15 TW TW097139649A patent/TWI341197B/en not_active IP Right Cessation
- 2003-05-15 KR KR10-2004-7018417A patent/KR20050003460A/en not_active Application Discontinuation
- 2003-05-15 PT PT81524894T patent/PT1944026E/en unknown
- 2003-05-15 KR KR1020107027288A patent/KR20100133027A/en not_active Application Discontinuation
- 2003-05-15 TW TW092113223A patent/TWI340036B/en not_active IP Right Cessation
- 2003-05-15 KR KR1020127004175A patent/KR20120025018A/en not_active Application Discontinuation
- 2003-05-15 DK DK08152489.4T patent/DK1944026T3/en active
Also Published As
Publication number | Publication date |
---|---|
KR101299873B1 (en) | 2013-08-23 |
KR20110094154A (en) | 2011-08-19 |
PL396723A1 (en) | 2011-12-19 |
TW200906381A (en) | 2009-02-16 |
KR20050003460A (en) | 2005-01-10 |
TW200307533A (en) | 2003-12-16 |
KR20100133027A (en) | 2010-12-20 |
DK1944026T3 (en) | 2013-09-30 |
SI1944026T1 (en) | 2013-10-30 |
KR20130088904A (en) | 2013-08-08 |
ES2428697T3 (en) | 2013-11-08 |
KR20120025018A (en) | 2012-03-14 |
TWI340036B (en) | 2011-04-11 |
PT1944026E (en) | 2013-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1482895A4 (en) | Aminoalkylphosphonates and related compounds as edg receptor agonists | |
AP1916A (en) | Purine compounds and use thereof as cannabinoid receptor ligands | |
EP1535610A4 (en) | Therapeutic agent for cancer | |
EP1482896A4 (en) | Aminoalkylphosphonates and related compounds as edg receptor agonists | |
PL383616A1 (en) | Agents binding and inhibiting miostatin | |
AU2003222604A8 (en) | Proteins involved in breast cancer | |
PL379553A1 (en) | Vanilloid receptor ligands and their use in treatments | |
AU2003213144A1 (en) | Alkylating agent combinations in the treatment of cancer | |
IL166396A0 (en) | Vanilloid receptor ligands and their use in treatments | |
AU2003235470A8 (en) | Predictive markers in cancer therapy | |
EP1482970A4 (en) | Cancer therapy | |
HUP0401903A3 (en) | Improved use of et-743 in cancer thereapy | |
HUP0300005A3 (en) | Modified cytokines for use in cancer therapy | |
TWI340641B (en) | N-acylamino benzyl ether derivatives | |
IL173265A0 (en) | Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazcpine receptor ligands | |
AU2003255544A8 (en) | Tumor specific oligosaccharide epitopes and use thereof | |
GB0204800D0 (en) | Dispensing wallets | |
IL161762A0 (en) | Estradiol inhibiting agents in breast cancer | |
HRP20041037A2 (en) | Binding agents and their use in targeting tumor cells | |
TWI341197B (en) | Use of edg receptor binding agents in cancer | |
GB0226595D0 (en) | Cancer therapy determination | |
EP1587405A4 (en) | Novel compositions and methods for cancer | |
AU2003221886A8 (en) | Beta2-microglobilin (beta2m) and anti-beta2m binding agents as anti-cancer therapeutics | |
EP1701736A4 (en) | Therapeutic agents and uses therefor | |
GB0305348D0 (en) | Membrane-associated protein in cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |